arrow
F

Francesca Cordero

University of Torino
H指数:34
被引数:6,843

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gut microbiome profiling at multiple sclerosis onset as a potential early prognostic marker of disease course: evidence from an observational cohort

多发性硬化症发作时的肠道微生物组分析作为疾病进程的潜在早期预后标志物:来自一项观察性队列的证据

2026-09-010
OAAI
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trial

通过分析微小残留病动态改善套细胞淋巴瘤的预后预测:意大利淋巴瘤基金会(FIL)MCL0208临床试验数据

2026-04-300
OAAI
Common genomic and transcriptomic signatures in Richter transformation highlight druggable vulnerabilities and guide drug repurposing strategies

Richter转化的共同基因组学和转录组学特征突显可用药脆弱性并指导药物重定位策略

Leukemia
IF13.4
2026-04-140
OAAI
Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer

Piccinno, G.; Thompson, K.N.; Manghi, P.; Ghazi, A.R.; Thomas, A.M.; Blanco-Miguez, A.; Asnicar, F.; Mladenovic, K.; Pinto, F.; Armanini, F.; et al. 对来自18个队列的3,741份粪便元基因组进行合并分析,以确定结直肠癌的可复现的跨阶段和菌株水平微生物生物标志物。Nat. Med. 2025, 31, 2416–2429. [Google Scholar] [CrossRef] [PubMed]

2025-06-030
OAAI
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens

在胰腺癌患者中,化疗重塑了T淋巴细胞的基因表达谱和抗原受体谱系,并增强了它们对肿瘤相关抗原的效应子反应

2024-08-081
OAAI
Modulation of faecal miRNAs highlights the preventive effects of a Mediterranean low-inflammatory dietary intervention
2024-04-012
OAAI
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial
2024-01-040
OAAI
A Fecal MicroRNA Signature by Small RNA Sequencing Accurately Distinguishes Colorectal Cancers: Results From a Multicenter Study
2023-09-0125
OA